$186 Thousand is the total value of Kopp Family Office, LLC's 22 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 4.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWM | Buy | ISHARES TRrussell 2000 etf | $35,943 | +14.4% | 158,465 | +8.2% | 19.37% | +2.5% |
VEA | Buy | VANGUARD TAX-MANAGED FDSvan ftse dev mkt | $29,575 | +16.6% | 654,745 | +8.3% | 15.94% | +4.4% |
NEO | Sell | NeoGenomics Inc | $22,477 | +60.4% | 1,291,019 | -14.9% | 12.11% | +43.6% |
FIVN | Buy | Five9 Inc | $19,098 | +6.9% | 264,190 | +0.4% | 10.29% | -4.3% |
VWO | Buy | VANGUARD INTL EQUITY INDEX Fftse emr mkt etf | $17,212 | +14.3% | 426,045 | +10.3% | 9.28% | +2.4% |
VCEL | Buy | Vericel Corporation | $16,575 | +12.7% | 565,318 | +1.2% | 8.93% | +0.9% |
JAMF | Buy | JAMF HOLDING CORP | $13,415 | -0.6% | 690,773 | +9.0% | 7.23% | -11.0% |
TEAM | Buy | Atlassian Corp PLCcl a | $8,967 | +33.6% | 52,386 | +0.4% | 4.83% | +19.6% |
WK | Buy | Workiva Inc | $4,527 | +148.6% | 44,207 | +103.8% | 2.44% | +122.6% |
MODN | Buy | Model N Inc | $4,015 | +138.4% | 119,966 | +188.9% | 2.16% | +113.4% |
Buy | Coherent Corp | $4,009 | +131.6% | 105,269 | +113.4% | 2.16% | +107.4% | |
VRDN | Buy | Viridian Therapeutics Inc | $3,340 | +77.6% | 131,288 | +103.9% | 1.80% | +59.0% |
INSP | Buy | Inspire Med Sys Inc | $3,332 | +89.6% | 14,235 | +104.0% | 1.80% | +69.8% |
MITK | Buy | MITEK SYS INC | $2,520 | -0.8% | 262,805 | +0.2% | 1.36% | -11.2% |
IEFA | ISHARES TRcore msci eafe | $170 | +8.3% | 2,547 | 0.0% | 0.09% | -2.1% | |
ISTB | ISHARES TRcore 1 5 yr usd | $98 | +2.1% | 2,070 | 0.0% | 0.05% | -8.6% | |
IVV | ISHARES TRcore s&p500 etf | $92 | +7.0% | 223 | 0.0% | 0.05% | -3.8% | |
IEMG | ISHARES TRcore msci emkt | $71 | +4.4% | 1,455 | 0.0% | 0.04% | -7.3% | |
IAGG | ISHARES TRcore intl aggr | $39 | +2.6% | 806 | 0.0% | 0.02% | -8.7% | |
IMTB | ISHARES TRcr 5 10 yr etf | $37 | +2.8% | 834 | 0.0% | 0.02% | -9.1% | |
IJH | ISHARES TRcore s&p mcp etf | $28 | +3.7% | 113 | 0.0% | 0.02% | -6.2% | |
IJR | ISHARES TRcore s&p scp etf | $16 | 0.0% | 164 | 0.0% | 0.01% | -10.0% | |
HZNP | Exit | Horizon Therapeutics Pub L | $0 | – | -136,895 | -100.0% | -9.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NeoGenomics Inc. | 16 | Q3 2023 | 90.1% |
Vericel Corporation | 16 | Q3 2023 | 14.5% |
Five9, Inc. | 16 | Q3 2023 | 11.2% |
ISHARES TR | 13 | Q3 2023 | 16.7% |
ISHARES TR | 13 | Q3 2023 | 10.6% |
ISHARES TR | 13 | Q3 2023 | 0.1% |
ISHARES TR | 13 | Q3 2023 | 0.1% |
ISHARES TR | 13 | Q3 2023 | 0.0% |
ISHARES TR | 13 | Q3 2023 | 0.0% |
ISHARES TR | 13 | Q3 2023 | 0.0% |
View Kopp Family Office, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
RTI Surgical Holdings, Inc. | July 07, 2020 | ? | ? |
NEOGENOMICS INC | January 07, 2020 | 4,844,625 | 4.6% |
OCLARO, INC. | January 04, 2019 | ? | ? |
SUPERCONDUCTOR TECHNOLOGIES INC | October 05, 2018 | ? | ? |
View Kopp Family Office, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-16 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-15 |
13F-HR | 2021-11-16 |
View Kopp Family Office, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.